Abstract: One subject of the present invention is a composition that combines at least one polyamide having at least one MXD entity, MXD denoting meta-xylylenediamine or a mixture of meta-xylylenediamine and of para-xylylenediamine, with a bioresourced reinforcement. The invention also relates to the conversion of these compositions, by injection moulding or extrusion, into objects that have good mechanical properties, said objects corresponding to technical application specifications such as may be found, for example, in the automotive industry, construction, sport and in electrical or electronic fields.

Abstract: The present invention is directed to methods and systems for rendering perceivable stimuli representative of information processing by a multi-tenant architecture that pre-fetches a portion of a subset of data on a multi-tenant architecture and emulates a result set of data in accordance with a report definition. To that end the method comprises identifying a subset of data on the multi-tenant architecture that is subject to a report definition. A portion of the subset is pre-fetched and analyzed to emulate a result. The emulated result is transmitted to a computer system of a user of the multi-tenant architecture. Perceivable stimuli is generated on the user computer system, in response to receiving the emulated result.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for displaying one or more data sets to a user. These mechanisms and methods for displaying one or more data sets to a user can enable enhanced data security, more relevant data display, reduced processing, etc.

Abstract: The invention relates to a polymer obtained by polymerizing olefins having 6 to 9 carbon atoms and partially derived from renewable resources. In particular, the polymer according to the invention can be derived from vegetable oil or animal fat. The invention also relates to the method for producing the polymer.

Abstract: The invention relates to a polyamide comprising at least two units having the following general formula: 4.Y in which: 4 denotes butanediamine, and Y represents a dicarboxylic acid chosen from a linear or branched aliphatic dicarboxylic acid, a cycloaliphatic diacid and an aromatic diacid, the dicarboxylic acid containing from 7 to 11 carbon atoms, the butanediamine contains carbon of renewable origin, except for the fact that when the polyamide is a copolyamide, it cannot contain 100% by mass of organic carbon derived from renewable raw materials relative to the total mass of polyamide carbon. The invention also relates to a composition comprising this polyamide and the use of this polyamide and of such a composition.

Abstract: The invention relates to a polyamide comprising at least two units having the following general formula: X.Y where: X is an alkylaromatic diamine and Y is an aliphatic carboxylic diacid selected from dodecanedioic (C12) acid, tetradecanedioic (C14) acid, hexadecanedioic (C16) acid, characterized in that the carboxylic diacid comprises organic carbon from a renewable source determined according to standard ASTM D6866 The invention also relates to a composition comprising this polyamide and the use of said polyamide and of such a composition.

Abstract: The invention relates to a method for production of grafted polyethylene comprising the following steps: a) fermentation of primary renewable material with optional purification to give at least one alcohol chosen from ethanol or a mixture of alcohols comprising ethanol; b) dehydration of the alcohol obtained to give in a first reactor at least one alkene selected from ethylene and mixtures of alkenes containing ethylene and optional purification of the alkene to give ethylene; c) polymerization, in a second reactor, of the ethylene to give polyethylene; d) isolation of the polyethylene obtained in step c); e) grafting the polyethylene with at least one grafting monomer selected from the unsaturated carboxylic acids or theifunctional derivatives thereof, the unsaturated dicarboxylic acids having 4-10 carbon atoms and the functional derivatives thereof being C1-C8 alkyl esters or glycidyl ester derivatives of the unsaturated carboxylic acids and the metal salts of the unsaturated carboxylic acids.

Abstract: The invention relates to a polyamide comprising at least one repeat unit corresponding to the general formulation: X·Y in which: X represents a cycloaliphatic diamine and Y represents an aliphatic dicarboxylic acid chosen from dodecanedioic (C12) acid, tetradecanedioic (C14) acid and hexadecanedioic (C16) acid, characterized in that said dicarboxylic acid comprises organic carbon of renewable origin, determined according to Standard ASTM D6866. The invention also relates to a composition comprising this polyamide and also to the use of this polyamide and of such a composition.

Abstract: The invention relates to a copolyamide containing at least two patterns (monomers) and of the following general formula A/(Cz diamine)·(Cw diacid) in which: z is the number of carbon atoms of the diamine and w is the number of carbon atoms of the diacid; and A is selected from a pattern obtained from an amino acid and a pattern of the general formula (Cx diamine)·(Cy diacid)y, wherein x is the number of carbon atoms of the diamine and y is the number of carbon atoms of the diacid, the amino acid, each diamine and each diacid being obtained from a renewable raw material according to ASTM D6866 standard. The invention also relates to a composition containing the copolyamide and to the use of this copolyamide and of such a composition, essentially for producing thermofusable glues, in any form thereof.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if appropriate also in the form of the physiologically tolerable acid addition salts or N-oxides. Furthermore, the invention also includes antitumor agents comprising as active compound one or more N-substituted indole-3-glyoxylamides according to the general formula 1 and, if appropriate, their physiologically tolerable acid addition salts and, if possible, N-oxides and a pharmaceutically utilizable carrier and/or diluent or auxiliary substance in the form of tablets, coated tablets, capsules, solutions for infusion or ampoules, suppositories, patches, powder preparations which can be employed by inhalation, suspensions, creams and ointments.

Abstract: The present invention relates to a process for the preparation of dimethylketene (DMK) and then of polydimethylketene (PDMK) by polymerization of DMK. More specifically, the DMK is obtained by pyrolysis by isobutyric anhydride (IBAN), the latter decomposing under the effect of heat (pyrolysis) to give isobutyric acid (IBA) and DMK. One mole of pyrolyzed IBAN gives one mole of IBA and one mole of DMK.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if appropriate also in the form of the physiologically tolerable acid addition salts or N-oxides. Furthermore, the invention also includes antitumor agents comprising as active compound one or more N-substituted indole-3-glyoxylamides according to the general formula 1 and, if appropriate, their physiologically tolerable acid addition salts and, if possible, N-oxides and a pharmaceutically utilizable carrier and/or diluent or auxiliary substance in the form of tablets, coated tablets, capsules, solutions for infusion or ampoules, suppositories, patches, powder preparations which can be employed by inhalation, suspensions, creams and ointments.

Abstract: The invention concerns a cationic catalyst system comprising an initiator (I), a catalyst (K) and a cocatalyst (CoK). The cocatalyst (CoK) is an agent releasing the active polymerizing center of its counter anion generated by the reaction between the catalyst (K) and the initiator (I). Said cocatalyst is characterized by the existence of a double bond electron-depleted by an electroattractive group. It is selected, for example, from the group consisting of the following complexing agents including o-chloranyl (3,4,5,6-tetrachloro-1,2-benzoquinone), p-chloranyl (2,3,5,6-tetrachloro-1,4-benzoquinone), nitrobenzene, trinitrobenzene, or tetracyanoethylene.

Abstract: The invention concerns a cationic catalyst system comprising an initiator (I), a catalyst (K) and a cocatalyst (CoK). The cocatalyst (CoK) is an agent releasing the active polymerizing center of its counter anion generated by the reaction between the catalyst (K) and the initiator (I). Said cocatalyst is characterized by the existence of a double bond electron-depleted by an electroattractive group. It is selected, for example, from the group consisting of the following complexing agents including o-chloranyl (3,4,5,6-tetrachloro-1,2-benzoquinone), p-chloranyl (2,3,5,6-tetrachloro-1,4-benzoquinone), nitrobenzene, trinitrobenzene, or tetracyanoethylene.

Abstract: Compound of formula (I): wherein: R1 and R2, which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R4 represents hydrogen or alkyl, R5 represents hydrogen, alkyl, aryl or heteroaryl, R3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.

Abstract: The present invention relates to novel indole derivatives, their method of preparation and their pharmacological activity as antimycotic and/or antiparasitic compounds.

Abstract: Compound of formula (I): wherein: Het1 and Het2, which may be identical or different, each represents an optionally substituted pyridyl, A represents a bond or linear or branched (C1-C6)alkylene, its optical isomers, where they exist, and addition salts thereof with a pharmaceutically acceptable acid.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents 1

Abstract: The invention relates to a method and a device for air conditioning for an aircraft cabin (30) comprising at least two distinct turbomachines (1, 2), at least one of which is motorised. When the pressure difference between the cabin and the atmosphere is greater than an upper pressure difference threshold, an economy mode is activated, in which the second turbine stage (23) is supplied exclusively by an air output obtained from the cabin (30). When the pressure difference is lower than a lower pressure difference threshold, a cold mode is activated, in which the compression stages (11, 21) of the turbomachines (1, 2) are connected in series. The drive speed of at least one motor (12, 22) is adjusted such as to adjust the refrigerating power supplied.

Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents 1